Share
2018 Annual Report

Now Available

Inbrija Logo

On December 21, 2018, the FDA approved INBRIJA for the intermittent treatment of OFF episodes, also known as OFF periods, in adults with Parkinson’s disease taking carbidopa/levodopa.

Learn More

Our mission is to develop therapies that restore function and improve the lives of people with neurological disorders.

ACORDA, ACORDA THERAPEUTICS, the stylized ACORDA THERAPEUTICS LIFE. SCIENCE. mark, AMPYRA, INBRIJA, the INBRIJA logo, ARCUS, THE MANY FACES OF OFF, Live Well. Do Tell., the Live Well. Do Tell. logo, and Framing OFF Through Art are all trademarks of Acorda Therapeutics, Inc. ©2019 Acorda Therapeutics, Inc. All rights reserved.